Literature DB >> 8083977

Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

C J Miller1, M Marthas, J Torten, N J Alexander, J P Moore, G F Doncel, A G Hendrickx.   

Abstract

The simian immunodeficiency virus (SIV)-rhesus macaque model of heterosexual human immunodeficiency virus transmission consists of atraumatic application of cell-free SIVmac onto the intact vaginal mucosa of mature female rhesus macaques. This procedure results in systemic infection, and eventually infected animals develop the clinical signs and pathologic changes of simian AIDS. To achieve 100% transmission with the virus stocks used to date, multiple intravaginal inoculations are required. The current titration study utilized two stocks of SIVmac and demonstrated that a single intravaginal dose of cell-free SIV can reliably produce infection in rhesus macaques. This study also demonstrated that some animals intravaginally inoculated with cell-free SIVmac develop transient viremia characterized by a limited ability to isolate virus from peripheral blood mononuclear cells and lymph node mononuclear cells and no seroconversion to SIV antigen. SIV could be isolated from the peripheral lymph nodes of transiently viremic animals only during periods of viremia and not at times when SIV was not detected in circulating mononuclear cells. Thus, peripheral lymphoid tissues were not reservoirs of infection in the transiently viremic animals. Taken together, these results suggest either that the SIV infection was cleared in the transiently viremic animals or that SIV infection is limited to a compartment of the genital mucosal immune system that cannot be assessed by monitoring SIV infection in peripheral blood mononuclear cells and peripheral lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083977      PMCID: PMC237059     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.

Authors:  K D Bird
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

2.  Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.

Authors:  S Sutjipto; N C Pedersen; C J Miller; M B Gardner; C V Hanson; A Gettie; M Jennings; J Higgins; P A Marx
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Continuous measurement by radio-telemetry of vaginal pH during human coitus.

Authors:  C A Fox; S J Meldrum; B W Watson
Journal:  J Reprod Fertil       Date:  1973-04

4.  Detecting SIV gp120 and its interaction with soluble CD4 by ELISA.

Authors:  J P Moore; Q J Sattentau
Journal:  AIDS Res Hum Retroviruses       Date:  1993-12       Impact factor: 2.205

5.  Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.

Authors:  C J Miller; N J Alexander; S Sutjipto; S M Joye; A G Hendrickx; M Jennings; P A Marx
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

6.  Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus.

Authors:  M L Marthas; B Banapour; S Sutjipto; M E Siegel; P A Marx; M B Gardner; N C Pedersen; P A Luciw
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667

7.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.

Authors:  K Saksela; E Muchmore; M Girard; P Fultz; D Baltimore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.

Authors:  C J Miller; N J Alexander; S Sutjipto; A A Lackner; A Gettie; A G Hendrickx; L J Lowenstine; M Jennings; P A Marx
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.

Authors:  M Kannagi; M Kiyotaki; R C Desrosiers; K A Reimann; N W King; L M Waldron; N L Letvin
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

10.  Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  K A Reimann; K Tenner-Racz; P Racz; D C Montefiori; Y Yasutomi; W Lin; B J Ransil; N L Letvin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  70 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.

Authors:  S L Buge; E Richardson; S Alipanah; P Markham; S Cheng; N Kalyan; C J Miller; M Lubeck; S Udem; J Eldridge; M Robert-Guroff
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus.

Authors:  Christopher J Miller; Qingsheng Li; Kristina Abel; Eun-Young Kim; Zhong-Min Ma; Stephen Wietgrefe; Lisa La Franco-Scheuch; Lara Compton; Lijie Duan; Marta Dykhuizen Shore; Mary Zupancic; Marc Busch; John Carlis; Steven Wolinsky; Steven Wolinksy; Ashley T Haase
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites.

Authors:  Ivona Pandrea; Nicholas F Parrish; Kevin Raehtz; Thaidra Gaufin; Hannah J Barbian; Dongzhu Ma; Jan Kristoff; Rajeev Gautam; Fang Zhong; George S Haret-Richter; Anita Trichel; George M Shaw; Beatrice H Hahn; Cristian Apetrei
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

6.  Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.

Authors:  Qing Wei; Patricia N Fultz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.

Authors:  Pushpa Jayaraman; Tuofu Zhu; Lynda Misher; Deepika Mohan; LaRene Kuller; Patricia Polacino; Barbra A Richardson; Helle Bielefeldt-Ohmann; David Anderson; Shiu-Lok Hu; Nancy L Haigwood
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Authors:  Alexandra Mumbauer; Agegenhu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

9.  Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

Authors:  M S Wyand; K H Manson; M Garcia-Moll; D Montefiori; R C Desrosiers
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.